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Abstract
Fourier transform infrared (FTIR) spectroscopy is a highly versatile tool for cell and tissue analysis.
Modern commercial FTIR microspectroscopes allow the acquisition of good-quality hyperspectral images
from cytopathological samples within relatively short times. This study aims at assessing the abilities
of FTIR spectra to discriminate different types of cultured skin cell lines by different computer analysis
technologies. In particular, 22700 single skin cells, belonging to two non-tumoral and two tumoral cell
lines, were analysed. These cells were prepared in three different batches that included each cell type.
Different spectral preprocessing and classification strategies were considered, including the current standard
approaches to reduce Mie scattering artifacts. Special care was taken for the optimisation, training and
evaluation of the learning models in order to avoid possible overfitting. Excellent classification performance
(balanced accuracy between 0.85 and 0.95) was achieved when the algorithms were trained and tested
with the cells from the same batch. When cells from different batches were used for training and testing
the balanced accuracy reached values between 0.35 and 0.6, demonstrating the strong influence of sample
preparation on the results and comparability of cell FTIR spectra. A deep study of the most optimistic
results was performed in order to identify perturbations that influenced the final classification.
Keywords: Machine learning, Multivariate analysis, Cancer diagnosis, Cytopathology, Fourier transform
infrared spectroscopy
1. Introduction
Infrared spectroscopy is a highly promising opti-
cal technology in the combined identification and
localization of pathophysiological cell and tissue
alterations [1]. A limiting factor for the use of
Fourier Transform Infrared (FTIR) spectroscopes
in biomedical problems has been the sensitivity of
the systems, which is related to the relatively high
acquisition times needed to obtain measurements
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of sufficient quality. This problem is of greater con-
cern for single layers and/or individual cells, which
contain less biological material than tissues and
provide lower signals. Therefore, to obtain spec-
tra from cells with signal-to-noise ratio comparable
to tissues, the acquisition time is normally on the
order of two or even four times higher for cells than
for tissue. Moreover, the measurement of cells has
normally been a very tedious task because they are
frequently spread out in the sample preparations.
These facts have hampered the proper analysis of
cell spectra and prevented the systematic assess-
ment of their discriminative power.
Recently, modern FTIR microspectroscopes have
increased their acquisition speed mainly thanks to
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the development of larger and more sensitive imag-
ing sensors. The present work constitutes a proof-
of-concept to assess if a modern benchtop FTIR
microspectroscope, together with the existing pro-
tocols of sample preparation and spectral analysis,
are ready to provide a reliable diagnostic system
using cytological samples. In particular, the abil-
ity of FTIR spectra to differentiate between cells
from cultures of four different skin cell lines, includ-
ing two melanoma cell lines with malignant pheno-
types, was studied.
1.1. Related work
Because of the aforementioned difficulties, the
application of FTIR microspectroscopy to cy-
topathological problems is considerably less than
the large number of studies and significant advances
accomplished in histopathology. Nevertheless, sev-
eral research groups around the world have pushed,
and still push, forward with its application and de-
velopment.
Until the advent of FTIR microscopes, cytologi-
cal studies analysed average FTIR spectra recorded
from large samples of cell pellets, which lacked
enough spatial resolution to accurately distinguish
cell subpopulations [2]. The first relevant studies
of cells by combining FTIR spectroscopes and op-
tical microscopy were performed with synchrotron
sources around the beginning of this century [3, 4].
In fact, these kinds of facilities were used in pioneer-
ing studies that revealed one of the main problems
in FTIR cytology: Mie scattering and Resonant
Mie Scattering (RMieS) [5–7]. Improvements in op-
tical components and sensor sensitivities extended
the use of FTIR microspectrometers with thermal
sources to laboratories. In addition, the introduc-
tion of Focal Plane Array (FPA) sensors enabled
faster measurements of cell preparations [8].
The most relevant bibliography involving FTIR
cell analyses can be found in recent reviews [9, 10].
Regarding the discrimination of cells from the di-
agnostic point of view, commonly referred to as
Spectral Cytopathology (SCP), the most important
works using FTIR microscopy are mainly related to
Diem’s collaborations [11–18]. All these studies are
focused on smear cells directly extracted from dif-
ferent parts of the patients rather than in cell cul-
tures. They have covered different types of cancer
pathologies: urine [14], cervix [15] or upper respira-
tory and digestive tract [16–18]. In most of them,
cells were deposited on low-e slides and measured
in transflection. Due to the preparation of the ex-
tracted samples, cells were relatively spread and
isolated. A patented method called PapMap [8],
which computes a mean spectrum per isolated cell
and discards clumped cells, is used in those stud-
ies. It should be noted that there is a fair amount
of debate regarding the viability of using transflec-
tion with samples of varying thickness, due to inter-
ference effects between illumination and reflection
photons [19–21].
As stated above, most existing studies related
to cancer discrimination analyse cells directly ex-
tracted from the patient. In principle, this is the
ideal methodology to develop decision support sys-
tems to assist the clinician in the diagnosis of cy-
topathological samples. Nevertheless, one of the
problems of using these kinds of samples is the
need for an explicit labelling by expert patholo-
gists, which is considered the ground truth, or gold
standard. This process is very time-consuming for
the experts and is also subject to their interpreta-
tion. In addition, most of the extracted cell samples
contain debris and undesirable heterogeneities that
may diminish the quality and reliability of the cell
datasets. These problems, added to the intrinsic
difficulties when recording FTIR spectra of cells,
have resulted in most existing studies being based
on reduced datasets of spectra (e.g., less than 1000
cell spectra). As a consequence, their results are
generally founded on just qualitative assessments
(e.g., by means of Principal Component Analysis
(PCA) scores plots) or quantitative classifications
where no clear separations of the training and test
sets are stated. Hence, their findings offer limited
statistical significance and generalisation capabili-
ties of the models are very difficult to guarantee, es-
pecially given the high-dimensional nature of FTIR
spectra.
Finally, a preliminary study to discriminate skin
cell lines by using a reduced dataset of individual
FTIR spectra was carried out in a previous publi-
cation [22]. Nevertheless, the relevance of the ob-
tained results was limited, since the number of anal-
ysed cells was much lower than in this work. In
addition, it did not incorporate the variability due
to the measurement and preparation, as it only em-
ployed a single hyperspectral image per cell line.
1.2. Objective of the study
The main objective of this study is to assess the
capabilities of FTIR spectra to discriminate differ-
ent skin cell lines, comprising two non-tumoral and
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two tumoral types. These cell lines were cultured
and fixed in a controlled environment before being
measured with a modern state-of-the-art commer-
cial FTIR microspectrometer. The selected cellular
models are rather stable and have significant dif-
ferences in tumorigenicity. Cultured cells belong to
catalogued cell lines with approximately constant
characteristics within the same populations, which
reduces the uncertainty linked to the establishment
of a reliable ground truth. Thus, they provide more
homogeneous genotypic and morphologic character-
istics during a series of experiments than cell or
tissue samples from different patients. In addition,
cell cultures provide higher spatial densities of cells,
which increases the efficiency for recording larger
amounts of data. Thus, these cultured cells should
potentially constitute a suitable standard model for
the evaluation of the processing and classification
of FTIR cell spectra with higher levels of statistical
significance than current related studies.
Nevertheless, some technical problems and addi-
tional difficulties arise when dealing with cell cul-
tures. Some of these particularities introduce con-
founding artefacts that may mislead the discrimina-
tion. The aim of this work is to apply different data
analysis methodologies that diminish those critical
biases and promote a discrimination based on the
genuine biochemical information of the cell lines.
Special efforts will be made to evaluate the general-
isation capabilities and robustness of those method-
ologies against possible fluctuations in experimental
conditions. This variability, introduced both during
sample preparation and spectral acquisition, will be
also considered during the discrimination analysis.
Therefore, another goal of this work is to identify
the possible limitations of the current measurement
and sample preparation protocols.
2. Materials and methods
2.1. Discrimination pipeline
Fig.1 shows the flow diagram with the main steps
that were followed to discriminate skin cell lines, in-
cluding melanoma and non-melanoma cells, based
on their FTIR spectra. This process starts with
the preparation of cultured samples of catalogued
skin cell lines and their measurement with a modern
FTIR microspectroscope in order to obtain the hy-
perspectral images. From these images, the pixels
associated with cells were separated from the non-
cell pixels so that only useful spectra were retained
for subsequent steps.
FTIR spectra extracted from the retained pix-
els were individually preprocessed by different tech-
niques to normalise their values and remove un-
wanted variations which may mislead the posterior
quantitative analysis. A mean spectrum was com-
puted for each cell in order to reduce the complexity
of the dataset and try to mitigate remaining unde-
sirable effects in the preprocessed spectra of individ-
ual pixels, such as random noise. The anomalous or
extreme values in the dataset of mean cell spectra
were filtered out to promote stability and reduce
bias in the dimensionality reduction and classifica-
tion algorithms.
An exploratory analysis was performed in the re-
sulting dataset in order to study the main trends
within the data. Finally, the kept mean cell spec-
tra went through a process of feature extraction
and supervised classification where different alter-
natives were explored, too. This final process of
classification was subject to a methodology called
nested Cross-Validation (CV) consisting of two
loops, which separates the training and testing sub-
sets of spectra in order to avoid over-fitting and give
a reliable measurement of the performance of the
constructed classification algorithms. All of these

























Figure 1: Flow diagram of the main steps applied for the
discrimination of skin cells.
2.2. Hyperspectral images
2.2.1. Cell culture and sample preparation
Tab.1 summarises the cell lines used in this study.
With the use of these cell lines, the two major cellu-
lar skin constituents, keratinocytes (HaCaT) and fi-
broblasts (NIH-3T3), together with two skin cancer
cell types (A-375, SK-MEL-28) are represented. All
cell lines were cultured in DMEM (Sigma-Aldrich)
supplemented with 10% FBS (PAN-Biotech), 2 mM
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Table 1: Information about the cell lines used in this study.
Cell line Species Origin Type Provider Catalogue number
A-375 Homo sapiens Skin Malignant melanoma CLS 300110
HaCaT Homo sapiens Skin Keratinocytes CLS 300493
NIH-3T3 Mus musculus Embryo Fibroblasts DSMZ ACC 59
SK-MEL-28 Homo sapiens Skin Malignant melanoma CLS 300337
L-Glutamine (Lonza) and 1 mM sodium pyruvate
(Lonza) at 37 ◦C and 5% CO2. All cell lines
tested negative for mycoplasma. For FTIR analy-
sis, cells were grown on CaF2 windows (grade VUV,
12.5 × 12.5 × 1.5 mm3, CRYSTAL GmbH) for 24
hours using silicone micro inserts (4 well, ibidi).
These inserts enable to separate cultivation of up
to four cell lines on the same window. After remov-
ing the inserts, CaF2 windows were rinsed carefully
with PBS to remove loose cells. Remaining cell
layers were fixed with glutaraldehyde (1% in PBS)
for 30 min, dehydrated in an ascending ethanol se-
ries, and airdried. More detailed information about
the cell culture and the sample preparation can be
found in previous publications [23–25].
2.2.2. FTIR measurements
The measurement system consisted of an Agilent
620 FTIR microscope coupled to an Agilent 670
FTIR spectrometer with a Globarr light source
and a liquid nitrogen cooled FPA detector with
128 × 128 pixels. IR light was transmitted through
a 15× Cassegrain reflective condenser and objec-
tive (NA = 0.62) giving an effective pixel size of
5.5 × 5.5 µm2 and a corresponding field of view
(FOV) of 704× 704 µm2 per frame. Six frames per
sample were taken and combined, covering a hor-
izontal and vertical area of around 2.1 × 1.4 mm2
that included the whole cell culture. The measure-
ments were carried out in transmission mode and
absorption spectra were acquired between 1000-
3900 cm−1 with a wavenumber interval of 4 cm−1.
The images of the reference backgrounds (taken
from regions of empty substrate) and the images
of the cell samples were created by co-adding 256
and 128 scans, respectively.
2.2.3. Batches definition
Cells from each cell line were independently cul-
tured and later seeded and fixed separately in spe-
cific regions of a CaF2 window forming a cell sam-
ple. The separation of these regions were delimited
by silicone inserts or moulds with four rectangu-
lar holes that were attached to the CaF2 window
before cell seeding and were removed after fixation.
Fig.2 shows the representative grayscale images ob-
tained from the FTIR hyperspectral images of all
the cell samples that were prepared and measured
for this study. As can be observed, three samples
per cell line were measured giving a total of twelve
cell samples.




Figure 2: FTIR grayscale images of the measured samples
of skin cultured cell lines. Images from different cell lines
are arranged by columns and from different batches by rows.
The red dotted line reminds that images of HaCaT cells from
Batch 2 and Batch 3 were cultured in a separate CaF2 win-
dow. Green scale bars represent 1 mm.
These samples have been arranged in different
batches according to preparation and measurement
criteria:
• The samples within Batch 1 were cultured at
the same time and later seeded and fixed in the
same CaF2 window. They were also measured
during the same day.
• The samples within Batch 2 and Batch 3, with
the exception of the samples of HaCaT cell line,
were cultured at the same time (around one
year and a half later than cells from Batch 1 )
and were also seeded and fixed in two separate
CaF2 windows. HaCaT samples of Batch 2
and Batch 3 were later cultured (3 months
later) and seeded and fixed in a separate CaF2
window due to problems during the prepara-
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tion of that cell line in the original CaF2 win-
dows of those batches. Finally, all the sam-
ples from Batch 2 and Batch 3 (including Ha-
CaT cells) were measured during the same day
in the FTIR microspectrometer, around nine
months after acquiring the images of Batch 1.
This time delay was due to the complexity of
preparing the cell cultures and several difficul-
ties during the measurement logistics (e.g., cell
cultures were prepared and measured in labo-
ratories of different countries).
Both preparation and measurement factors intro-
duce variations in the FTIR spectra, which deter-
mine the strategies of the quantitative analysis and
will also have influence in the obtained results.
2.3. Spectra extraction
The first step in the analysis of the FTIR hy-
perspectral images is to separate pixels contain-
ing cell structures from those containing only sub-
strate. This separation was obtained by a binary
mask, which was automatically calculated by apply-
ing Otsu’s method [26] to a representative grayscale
image computed from the FTIR data cube. Further
details of this procedure can be found in the Elec-
tronic Supplementary Information (ESI).
2.4. Spectral preprocessing
Spectral preprocessing is normally recognised as
a key step in quantitative analysis of FTIR spectra,
especially for cytological studies [27–29]. In order to
better understand the need of spectral preprocess-
ing, Fig.3 shows some raw spectra corresponding to
pixels from different positions of a FTIR hyperspec-
tral image of NIH-3T3 cell line. Those pixels, whose
effective size is 5.5×5.5 µm2, have been overlaid on
independent white light images of higher resolution
aligned with the FTIR hyperspectral images. Ad-
ditional examples of raw spectra corresponding to
pixels from different regions of the four studied cell
lines can be found in the ESI.
As can be observed, even spectra from nearby
pixels in the same image can be highly variable.
Most of the gross variations are mainly determined
by differences in concentrations and optical path
lengths (thickness), which commonly result in off-
sets and multiplicative factors. Nevertheless, more
complex distortions can be observed in some cases,
showing the pattern distinctive of Mie scattering
and RMieS [7], e.g., complex baselines, lower ra-
tio between the Amide I peak (∼1600-1700 cm−1,
10 8 6 4
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Figure 3: Example of raw spectra extracted from a FTIR
hyperspectral image of NIH-3T3 cell line. Left plot: white
light image with a vertical line of selected pixels overlaid in
different colors. Green scale bar represents 50 µm. Right
plot: absorbance spectra corresponding to each pixel with
the same color. A proper offset has been added to each
spectrum for clarity.
with maximum around 1650 cm−1) and the Amide
II peak (∼1500-1600 cm−1, with maximum around
1545 cm−1), or derivative-like depressions beyond
the Amide I peak. By looking at the white light
images, those complex spectra can be associated
with regions where the cells are more compact and
rounded. Hence, they have characteristics that pro-
duce Mie scattering phenomena [5].
This morphological heterogeneity, which gives
rise to critical variations in the FTIR spectra, can
be related to different stages of the cell cycle, as was
demonstrated in previous studies [4, 30–32]. Those
studies showed that cells in stages G2 and close
to mitotic phase M have more compact structures
that increase the presence of RMieS artefacts. They
also demonstrated that FTIR spectra from cells of
the same cell type could be discriminated attending
to their stage in the cell cycle. In addition, some
other cells may have entered into apoptosis, due to
the high levels of cell stress that can appear locally
in the cell culture, acquiring compact and rounded
configurations too.
The main aim of spectral preprocessing is to nor-
malise and standardise the spectra so that they
can be categorised based on biochemical properties,
rather than unwanted physical properties (thick-
ness, concentrations, morphology, etc) that increase
the spectral variability and presumably can con-
found the discrimination. The raw spectra to-
gether with four different preprocessing methods
have been considered in order to study their pos-
sible influence in the discrimination of cell lines:
• Raw : original spectra without preprocessing.
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• Min-Max : Min-Max normalisation. Each
spectrum is scaled to between 0 and 1.
• SNV : Standard Normal Variate [33].
• DiffSG1 : 1st order differentiation by Savitzky-
Golay filter (2nd order polynomial and 19 fit-
ting points) and vector normalisation.
• RMieS-EMSC : Resonant Mie Scattering-
Extended Multiplicative Signal Correction
algorithm [34–36] after 20 iterations. It was
found empirically that 20 iterations is a
conservative number that generally gives a
stable correction.
Traditionally, the first three preprocessing meth-
ods (Min-Max, SNV and DiffSG1) have been
mainly applied in FTIR spectroscopic measure-
ments of tissues, although they have been also em-
ployed for cell spectra [37]. Nevertheless, since the
characterisation of RMieS artefacts [7] and the pub-
lication of RMieS-EMSC algorithm [34], it has gen-
erally become the default preprocessing method in
cytological studies.
The spectral range was cropped to the finger-
print region (1000-1800 cm−1). This restriction
was applied to the raw spectra and before prepro-
cessing except for the case of RMieS-EMSC, whose
spectra were cropped after preprocessing so that
the Mie scattering baselines could be modelled and
corrected more accurately with the information of
higher wavenumbers [6]. The RMieS-EMSC algo-
rithm also down-weighted the 2200-2550 cm−1 re-
gion associated with CO2 perturbations.
2.5. Mean cell spectra
The vast majority of cytological studies based on
FTIR hyperspectral images compute a mean or av-
erage spectrum per cell in order to reduce complex-
ity and increase the robustness of later analyses.
These mean spectra are computed after (instead of
before) preprocessing the raw spectra of individual
pixels independently in order to compensate for un-
even spectral distortions due to the heterogeneous
spatial properties of cells [31].
This approach is in line with object-based or
object-oriented classification approaches, which are
very popular in the analysis of hyperspectral images
in remote sensing [38]. Object-based approaches in-
corporate a certain level of spatial information that
generally improves the performance of pixel-wise or
pixel-by-pixel classification.
In order to compute mean cell spectra, it is essen-
tial to delimit the regions of pixels belonging to each
individual cell. The segmentation of cells was per-
formed with a methodology similar to the one pro-
posed by Filik et al. [39], which applies the marker-
controlled watershed transformation [40–42], with
some modifications, as further described in the ESI.
Finally, a mean cell spectrum per segmented re-
gion was computed by averaging the preprocessed
absorbance values of all the pixels’ spectra of that
segmented region along the wavenumber dimension.
2.6. Outliers removal
Outliers can seriously bias and deteriorate the
performance of the learning framework. The cor-
rect way of proceeding with outliers is attempting
to determine and address their causes in order to
detect possible failures in the followed methodolo-
gies [43]. In this problem, there are many sources
that may cause anomalous samples, starting from
the cell culture preparation, the acquisition of spec-
tra and finally in the previous steps of the classifi-
cation pipeline (e.g., spectral artefacts introduced
or not corrected during preprocessing). Due to
the complexity of the problem, the limited tech-
nological maturity of FTIR microspectroscopy and
the lack of standardised and universally-recognised
analysing protocols, it is reasonable to remove all
possible perturbations that may be caused by out-
liers and leave the (difficult) task of analysing out-
liers for future studies.
The whole dataset of mean spectra per segmented
cell region was studied to detect outliers. The pre-
processing option RMieS-EMSC was taken as a ref-
erence to define those cell regions whose mean spec-
tra are anomalous. This process was performed by
using PCA decomposition (retaining the first prin-
cipal components (PCs) that accounted for 99%
of total variance) and Mahalanobis distance (see
ESI for further details). The cell regions with
mean spectra preprocessed by RMieS-EMSC and
detected as outliers were discarded in all the pre-
processing alternatives described in Sec.2.4 in order
to keep the same set of cells for the final analysis.
2.7. Feature extraction
Feature extraction techniques aim to reduce the
number of variables included in the classification
models, to decrease their complexity and increase
their stability. The problem of high dimensional-
ity in hyperspectral images is commonly known as
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the Hughes phenomenon [44] in the remote sensing
field [45, 46]. In summary, this phenomenon states
that as the number of dimensions increases, the ef-
fectiveness of the classifier decreases. The main
reason is that the number of parameters involved
in the classification model increases with the num-
ber of dimensions and, for a fixed sample size, the
uncertainty in the estimation of those parameters
become wider [45]. PCA [47, 48] and Partial Least
Squares (PLS) [43, 49] were the methods used to
reduce the dimensionality of FTIR spectra and try
to prevent this problem. The number of retained
components K is a hyperparameter that was opti-
mised both for PCA and PLS in the inner loop of
the nested CV (see Sec. 2.9 and the ESI).
2.8. Supervised classification
Supervised classification is the task of pattern
recognition [50, 51] or machine learning [52] whose
goal is to create models capable of predicting or
inferring the labels, classes or groups of the sam-
ples from a dataset, taking as inputs a set of mea-
sured features. These models must be constructed
or trained with a set of samples whose labels or
classes are known. In this problem, the features
are the scores of the components retained in the
feature extraction step. These scores are used to
predict the label, i.e., the cell line, of each sample
or cell. As there are four different cell lines, this
study can be categorised as a multiclass classifica-
tion problem. Two main aspects must be defined in
the supervised classification step, namely the spe-
cific classification algorithm and the measurement
used to assess its performance.
2.8.1. Classification algorithms
Three classification algorithms or techniques,
very popular in the chemometrics field [49, 53], were
explored: Linear Discriminant Analysis (LDA),
Quadratic Discriminant Analysis (QDA) and Par-
tial Least Squares Discriminant Analysis (PLS-
DA). The main difference is in the definition of the
class boundary; hence, these three alternatives have
been considered to diminish their possible influence
in the final discrimination. LDA and QDA were
preceded by PCA as a feature extraction step. PCA
was not required for PLS-DA as feature extraction
is an inherent part of the algorithm already.
2.8.2. Assessment metric
Another important component in classification is
the metric for its evaluation. As the problem in
hand is a multiclass problem, a suitable assessment
metric is the overall accuracy [45, 54], which con-
denses the global classification performance of all
classes. As will be presented later (Tab. 2), a small
imbalance exists between the four classes of the
dataset, reaching almost a 3:1 ratio in some cases
(e.g., NIH-3T3/HaCaT in Batch 2, see Tab. 2). To
avoid favouring the larger classes [55, 56], the Bal-
anced Accuracy (BA) was used instead of the overall
accuracy to select the optimal models and to assess
the final multiclass classifications. BA is the mean









where Nc is the number of classes (4 in this case)
and cij is the number of spectra of class i classified
as class j. Hence, cii is the number of cell spectra
correctly classified for the class i.
2.9. Nested cross-validation
One of the main concerns in classification is to
obtain a reliable measure of the performance of the
developed models. In order to avoid, or at least di-
minish, over-fitting and assess generalization ability
of the classifier, the test and training sets of spectra
must be very well defined and separated during the
whole process of training, optimisation and assess-
ment of the learning framework [49, 52]. This task
was accomplished by applying a hierarchical CV
approach, called nested CV, which consists of two
loops: an outer loop for assessing the constructed
classification models and an inner loop for train-
ing and optimising those learning models. More
details about these two loops can be found in the
ESI. Following this structure, two cross-validations
alternatives were applied with the aim of checking
the dependency of the discrimination capabilities of
FTIR spectra on sample preparation and measure-
ment conditions.
2.9.1. Cross-validation alternatives
Once the CV method has been chosen, it is im-
portant to decide how the test, training and valida-
tion sets will be created from the whole dataset of
mean cell spectra that were retained after the re-
moval of outliers. The prediction capabilities of the
classification models are determined by the similar-
ities between the spectra from the test sets and the
training sets. In order to assess those similarities,
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two approaches were followed to separate the mean
cell spectra of each kind of set:
• One-Batch-Out CV : consecutively, the spectra
extracted from the images of one batch (Fig.2)
are considered as the test set in the outer loop
and the classification algorithms are trained
with the spectra of the other batches in the
inner loop. The process is repeated so that
each batch is considered once as the test set.
The results for each test batch are combined to
provide the final performance measurement (a
single value of BA). The idea behind this ap-
proach is to assess the uniformity of cell lines
between batches and to check if there may be
some critical factors for correct discrimination
(e.g., the sample preparation procedure or the
measurement conditions).
• In-Batch CV : as shown in Fig. 4 for Batch 1,
each image is split in 5 vertical stripes with
an equal number of segmented cells. Each ver-
tical stripe of the same color is considered as
the test set and the remaining stripes form the
training set. This is repeated until all stripes
have been in the test set once. The main rea-
son to group cells in vertical stripes, instead of
randomly choosing them for the test sets, is to
try to construct synthetic subimages where the
spatial variability within the same cell culture
is also assessed. When this process is finished
for one batch, it is repeated for the remaining
batches independently. The results for each
test stripe and batch are finally combined to
provide the final performance measurement (a
single value of BA). The aim of this approach is
to assess the discrimination between cell lines
inside each batch and to compare the perfor-
mance with the One-Batch-Out CV approach.
A-375 HaCaT NIH-3T3 SK-MEL-28
Batch 1
Figure 4: Sketch of the In-Batch CV approach. Each im-
age is split in 5 vertical stripes with an equal number of
segmented cells; CV is performed independently within each
batch by alternately considering one of the stripes from each
cell line as the test set and the rest of stripes as the training
set. Green scale bars represent 1 mm.
3. Results
3.1. Exploratory data analysis
Before presenting the final classification results,
it is very useful and even advisable to perform an
exploratory analysis of the data in search for trends
or patterns that may justify the outputs of the clas-
sification. This analysis is centred on the inputs of
the final classification module, that is, the mean cell
spectra after outliers removal (Fig. 1). This task
consists of visualising the main outputs of descrip-
tive statistics and PCA.
3.1.1. Descriptive statistics
Morphological information. The information about
the final number of segmented cell regions and their
corresponding number of pixels retained after out-
liers removal for each cell line and batch are pre-
sented in Tab. 2. A total of 22700 cells were re-
tained for the final analysis. As can be observed,
the number of cells varies between cell cultures.
The information of the total number of retained
cells and pixels can be complemented by the his-
tograms of pixels per cell shown in Fig. 5. The
majority of cells cover less than 20 pixels but there
are slight differences between samples and cell lines.
HaCaT cells tend to form more homogeneous mono-
layers and adopt flatter configurations than the
other cell lines, which is reflected in more uniform
histograms. On the contrary, malignant cell lines
(A-375 and SK-MEL-28) and in a less extent NIH-
3T3 cells normally grow in a more proliferative and
disordered way. As a result, those cell lines present
higher proportions of smaller cells, which also tend
to be more rounded and compact and, hence, more
liable to produce scattering artefacts.
Spectral information. The mean spectra for each
cell line and preprocessing alternative are presented
in Fig. 6. As can be observed, the differences be-
tween cell lines change depending on the prepro-
cessing. In fact, the order of presentation of the pre-
processing alternatives corresponds with the level
of differences observed. This order also agrees with
the complexity of each preprocessing method and
the level of transformation that individual spec-
tra experiment. In this sense, Min-Max alternative
broadly removes the offsets and applies a basic nor-
malisation. Therefore, with this preprocessing the
differences observed between cell lines are likely due
to Mie scattering artefacts and, by extension, to cell
morphology as evidenced by the uneven ratios of
8
Table 2: Information about the retained cells after outliers removal. Number of segmented cellular regions (first number) and
number of pixels inside them (second number) for each cell line (columns) and batch (rows). The last row and column present
the corresponding total marginal values.
A-375 HaCaT NIH-3T3 SK-MEL-28 Total
Batch 1 2247 / 35473 1638 / 41525 1750 / 31524 2495 / 34610 8130 / 143132
Batch 2 2438 / 31314 966 / 23367 2656 / 45348 1931 / 35875 7991 / 135904
Batch 3 1867 / 27906 875 / 20609 2318 / 45377 1519 / 32022 6579 / 125914
Total 6552 / 94693 3479 / 85501 6724 / 122249 5945 / 102507 22700 / 404950
Pixels(per(cell







































































































































































Figure 5: Histograms of pixels per cell in the final retained cells of each sample.
Amide I-Amide II peaks and remaining baselines.
Either way, it must be demonstrated if the reduc-
tion of undesirable artefacts with the most complex
preprocessing alternatives is necessary and effective
enough to discriminate, or improve the discrimina-
tion of, cell lines. More figures showing the central
tendency and dispersion of spectra from each batch
can be found in the ESI.
3.1.2. Principal component analysis
The capabilities of PCA for dimensionality reduc-
tion can be used to visualise the intrinsic structures
of hyperspectral datasets. Because PCA is an un-
supervised method (no information of the cell class
is used), their plots provide useful details about
the proximity or similarity between spectra and the
possible natural groups that they may form. Fol-
lowing this line, PCA can be used to extract prelim-
inary information from the different datasets which
each cross-validation alternative will have to deal
with.
In the case of One-Batch-Out CV, it is interest-
ing to explore the whole dataset of mean cell spec-
tra in order to study if there are relevant differ-
ences between the batches. The most important
plots after applying PCA to the whole dataset of re-
tained mean cell spectra are shown in Fig.7. Again,
RMieS-EMSC has been chosen as the reference pre-
processing because it is the most advanced alterna-
tive. In Fig. 7a, 100 mean cell spectra from each
cell line and batch have been randomly selected to
construct the score plots of the 2 first PCs. In that
plot, points from the same cell line have been drawn
with the same color and same symbols have been
used to identify points from each batch. As can
be observed, some subgroups of the same cell lines
seem to appear mainly from non-tumoral HaCaT
and NIH-3T3, which spread less than melanoma
cell lines A-375 and SK-MEL-28. Despite those lo-
cal subgroups, a global separation between cell lines
is not so evident.
In Fig. 7b the points belonging to each cell line
9
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Figure 6: Mean spectra computed with the datasets of average spectra per cell region that were retained after outliers removal
















































































































Figure 7: Principal component analysis of the whole dataset of retained mean cell spectra preprocessed by RMieS-EMSC.
(a) Score plots of the two first PCs with the corresponding percentage of explained variance in parentheses where 100 mean cell
spectra for each cell line (depicted with different colors) and batch (depicted with different symbols) have been randomly chosen
from the whole dataset. (b) Same score plots of subfigure (a) but showing only the randomly selected spectra of each cell line;
symbols used to denote the batch are the same as in subfigure (a) but colors have been changed to better identify differences
between batches. (c) Loadings of the 2 first PCs with the corresponding percentage of explained variance in parentheses.
have been isolated in distinct subplots in order
to better distinguish differences between batches
within each cell line. In those subplots, batches
have been denoted by the same symbols used in
Fig.7a but assigned different colors. As can be seen,
spectra from Batch 1 clearly tend to cluster sepa-
rately from the rest of batches in all cell lines. How-
ever, points from Batch 2 and 3, with the exception
of NIH-3T3, are much more overlapping. If these
subplots are compared with Fig. 7a, now spectra
from Batch 1 can be better identified in the lower
part of the graphs. In that batch, NIH-3T3 spectra
seem more isolated than the other cell lines. In ad-
dition, HaCaT cells from Batches 2 and 3 can be
better distinguished in the right central region more
or less mixed with NIH-3T3 spectra. Finally, spec-
tra from melanoma cell lines A-375 and SK-MEL-28
of Batches 2 and 3 are much more tangled in the
upper-central region of the chart.
Fig.7c displays the corresponding loading vectors
of the 2 first PCs. As observed, the highest weights
of the first PC (PC1), which explains 40.9% of the
total variance, are located around the Amide I peak
(∼1600-1700 cm−1, with maximum at 1653 cm−1)
and Amide II peak (∼1500-1600 cm−1, with max-
imum at 1543 cm−1). Other stronger weights oc-
cur around 1070 cm−1 and 1240 cm−1. The sec-
ond PC (PC2) explains 15.4% of the total variance
and it gives important clues about the presence of
two spectral artefacts. The first artefact is RMieS,
10
which can cause shifts in the maxima’s position of
the strongest absorption peaks and may be respon-
sible for the difference in the position of the maxi-
mum weight (1660 cm−1) with respect to PC1. The
second artefact is likely to be water vapour, which
may be responsible for the high-frequency fluctua-
tions throughout the range 1300-1800 cm−1.









































































































































































Figure 8: Principal component analysis of the subsets of re-
tained mean cell spectra from each batch (rows) preprocessed
by RMieS-EMSC. First column: Score plots of the two first
PCs, with the corresponding percentage of explained vari-
ance in parentheses, where 200 mean cell spectra for each
cell line (depicted with different colors) have been randomly
chosen from the corresponding batch’s subset. Second col-
umn: Loadings of the 2 first PCs with the corresponding
percentage of explained variance in parentheses.
In the case of In-Batch CV, the similarities be-
tween cell lines within each batch may be inferred
from the described study of the whole dataset.
However, it may be more convenient to analyse each
batch independently in order to reduce the interfer-
ences of other batches during the computation of
the main directions of variation. Fig. 8 shows the
most relevant plots when applying PCA to the sub-
sets of retained mean cell spectra preprocessed by
RMieS-EMSC from each batch.
The score plots of the 2 first PCs of each batch
(first column of Fig. 8) reveal congruent informa-
tion with the study of the whole dataset about
the relative dispersion of each cell line: HaCaT
and NIH-3T3 tend to form more compact sub-
groups, meanwhile A-375 and SK-MEL-28 are rela-
tively more spread. Concerning the separation be-
tween cell lines, slight differences can be observed
within each batch: in Batch 1, NIH-3T3 seems to
be the most isolated cell line followed by HaCaT,
which has partial overlaps with the other cell lines;
in Batch 2, HaCaT and SK-MEL-28 spectra seem
well separated but there is a significant overlap be-
tween A-375 and NIH-3T3; in Batch 3, HaCaT and
NIH-3T3 seem to overlap only partially with the
rest of cell lines, meanwhile A-375 and SK-MEL-28
spectra appear more mixed, as in Batch 1.
The loading vectors of the 2 first PCs (second
column of Fig. 8) again highlight the problems of
RMieS, which may be responsible for the shifts in
the maximum weights around the Amide I peak,
and water vapour. In particular, fluctuations likely
due to water vapour seem stronger in Batch 2,
clearly distorting the maximum weights. Finally,
although in Batch 1 the first PC is less relevant
than in the rest of batches, more than 80% and
95% of the total variance can be explained by re-
spectively retaining 5 and 15 PCs in all batches.
3.2. Classification results
The preliminary descriptive information of the
most relevant trends are based on two princi-
pal components and must be contrasted with
objectively-assessed classification models that con-
sider the whole dataset of cells and a larger num-
ber of components. Fig. 9 shows graphically the
final classification results in terms of Balanced Ac-
curacy (BA) for the combinations of explored pre-
processing options (Sec. 2.4), classification algo-
rithms (Sec. 2.8) and cross-validation alternatives
(Sec.2.9). Each final BA was computed by combin-
ing the predicted labels of the corresponding test
sets of mean cell spectra.
At first glance, there is an evident difference be-
tween the ranges of BA values obtained by the
two CV approaches. Meanwhile in One-Batch-Out
CV BA values range from around 0.35 to approx-
imately 0.6 (combination RMieS-EMSC and PCA-
QDA), in In-Batch CV all the combinations pro-






















































Figure 9: Classification results in terms of Balanced Ac-
curacy for the different preprocessing options (grouped by
rows), classification algorithms (colors) and cross-validation
alternatives: (a) One-Batch-Out CV and (b) In-Batch CV.
tion RMieS-EMSC and PLS-DA). Regarding pre-
processing, there is no clearly prevailing option
and the final performance also depends on the em-
ployed classification algorithm. Although the max-
imum BA values in both CV alternatives have been
reached by a combination including RMieS-EMSC.
If now we focus on the best combinations of each
CV alternative, further details may be obtained
about the underlying reasons to get those final BA
values. The aim is to gain deeper information about
why the misclassification may occur even in the best
scenario.
Firstly, it is worth studying the optimisation
curves of the number of retained components, com-
puted with the corresponding validation sets as was



























Figure 10: Optimisation curves for the best combination
(RMieS-EMSC and PCA-QDA) of One-Batch-Out CV.
described in Sec. 2.9. Figures 10 and 11 show the
optimisation curves for the best combinations of
One-Batch-Out CV and In-Batch CV, respectively.
In One-Batch-Out CV, a remarkably higher perfor-
mance (around double BA) is reached when the
Batch 1 is left out as test set and algorithms are
trained and validated only with the spectra from
Batch 2 and 3 than when one of those batches is
left out and the other one forms the initial train-
ing set with Batch 1. This fact confirms that
there are more similarities between spectra from
Batch 2 and 3 than with those from Batch 1,
which is in line with the preliminary studies by
PCA (Fig. 7). On the other hand, the optimisation
curves of In-Batch CV, individually constructed for
each batch by leaving out vertical stripes of cells in
the hyperspectral images, present much more simi-
lar characteristics between them. Even so, Batch 2
provides a slightly lower performance than the other
batches but in all cases BA is above 0.9. This sug-
gests a high degree of similarity between the spec-
tra from the same hyperspectral image and, hence,
from the same cell line, as well as relevant differ-
ences with other cell lines within the same batch.
Finally, again for the best combinations (highest
BA) of each CV alternative, the predicted cell labels
in the test sets were joined to create pseudo-color
images by using the color code shown in Fig. 12a.
Figures 12b and 12c respectively present those im-
ages for One-Batch-Out CV and In-Batch CV with
the same distribution of batches (rows) and cell
lines (columns) as in Fig. 2. Note that cells within
each image should be coloured with the color spec-
ified outside each column for a correct classifica-
tion. These images provide more detailed informa-
tion about the position of the misclassified spectra.
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Figure 11: Optimisation curves for the best combination (RMieS-EMSC and PLS-DA) of In-Batch CV.
When analysing Fig. 12b, some observations can
be stated about the classification performed by the
best combination of One-Batch-Out CV :
• Batch 1 : it presents the highest rate of mis-
classification. A significant amount of ma-
lignant A-375 cells are incorrectly labelled as
the benign NIH-3T3. The worst case is the
non-tumoral HaCaT cell line, whose cells are
mostly identified as the tumoral SK-MEL-28.
A small number of NIH-3T3 cells are con-
founded with cancerous A-375 cells. Lastly,
almost half of SK-MEL-28 cells are wrongly
classified as A-375.
• Batch 2 : the malignant A-375 cell line of this
batch is another case with extreme misclassifi-
cation, again with the benign NIH-3T3. How-
ever, the rest of cell lines are very well cate-
gorised.
• Batch 3 : A-375 cells are also mistaken with
NIH-3T3 but in a lower degree than in Batch 2.
The rest of cell lines present high rates of cor-
rect classification, although some cells from
NIH-3T3 and SK-MEL-28 are mainly confused
with the same cell types as in Batch 1.
• Overall : all batches classified A-375 and
NIH-3T3 either correct or as the corresponding
mesenchymal cell line. A-375 melanoma cells
are highly dedifferentiated and have a mes-
enchymal phenotype like fibroblasts (see ex-
tended discussion in the ESI). The One-Batch-
Out CV has therefore a strong performance
in the classification of cell types: mesenchy-
mal (A-375, NIH-3T3), epithelial (HaCaT) and
melanocyte (SK-MEL-28) rather than in the
identification of specific cell lines.
Finally, the images of the best combination of
In-Batch CV (Fig. 12c) confirm the good general
classification of most cells. The only remarkable
inaccuracies are mainly located in the malignant
A-375 and the benign NIH-3T3 cell lines of Batch 2,
whose cells are mutually confused with the other
cell line.
4. Discussion
The excellent classification results obtained in
the In-Batch CV suggest a high potential of FTIR
spectra to discriminate the skin cell lines, at least
inside each batch. Nevertheless, those high rates
of success are obtained independently of the pre-
processing technique and even for the raw spectra.
This fact warns that the results of the In-Batch CV
may be too optimistic and some level of over-fitting
may be playing a critical role. Those suspicions are
supported by the less favourable results obtained in
the One-Batch-Out CV alternative, which better
assesses the generalisation capabilities of the dis-
crimination framework.
Indeed, a deeper study of the most optimistic dis-
criminative option reveals that critical differences
exist, especially between cells from Batch 1 and the
other batches. These findings are also supported
by the unsupervised PCA score plots of the ex-
ploratory analyses. Taking into account that cells
from Batch 1 were prepared and measured at time
points different from Batch 2 and 3 (Sec. 2.2) and,
although similar sample preparation and measure-
ment protocols were followed for all batches, they
are likely to introduce confounding factors in FTIR
spectra which are critical for the correct discrim-
ination of cell lines. Nonetheless, when the ex-
perimental conditions are more comparable, as in
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A-375 HaCaT NIH-3T3 SK-MEL-28
(a)
A-375 HaCaT NIH-3T3 SK-MEL-28
(b)
A-375 HaCaT NIH-3T3 SK-MEL-28
(c)
Figure 12: Qualitative results. (a) Color code for the pre-
dicted labels of cells in the images of qualitative results.
(b) Qualitative results for the best combination (RMieS-
EMSC and PCA-QDA) of One-Batch-Out CV. (c) Quali-
tative results for the best combination (RMieS-EMSC and
PLS-DA) of In-Batch CV.
Batch 2 and 3, the extrapolation of the discrimina-
tion capabilities is more satisfactory.
These findings raise the question of whether the
discrimination of cells in this problem is critically
biased by the experimental factors. These factors
are mixed with the rest of physicochemical infor-
mation in the final hyperspectral images and dis-
covering the exact sources of these perturbations
is not easy. Despite this, the exploratory analy-
sis of preprocessed spectra has revealed the likely
undesirable presence of water vapour effects even
in the loadings of first PCs. These water vapour
fluctuations, which highly depend on the environ-
mental conditions during the spectral acquisition,
could not be avoided even when purging the sample
area with dry air. Those interferences, whose rela-
tive importance is higher in spectra with lower ab-
sorbance, increase their impact in the global dataset
due to the spectral normalisation.
The exploratory analyses also offered interesting
information about the efficiency and consequences
of the RMieS-EMSC algorithm, which is currently
the most advanced preprocessing method available
with a practical implementation. In this study, 20
iterations of the algorithm were used, which took
around 4 weeks to process the whole dataset of ex-
tracted individual spectra (around 400 thousand
in total). However, remaining shifts in the most
relevant weights of the PCA loadings around the
Amide I peak suggest a suboptimal correction of
RMieS artefacts. These artefacts, associated with
morphological differences, are accentuated by cell
culture conditions, where cells have sustained nu-
trients, support and enough space to proliferate,
favouring the presence of mitotic stages. Differ-
ences in growing and proliferation properties be-
tween cell lines are responsible for uneven sizes and
shapes, with tumoral cell lines more prone to be-
ing smaller and more compact. Therefore, Mie and
RMieS artefacts may have also played determinant
confounding roles in the discrimination of cell lines.
For example, this factor may be responsible for the
misidentification of A-375 cells as NIH-3T3 and vice
versa, although this misclassification may not be an
artefact of cell preparation or classification methods
but rather be caused by the high similarity of these
mesenchymal cell types (see extended discussion in
the ESI).
The identification of cell types is a crucial effort
towards an identification and localisation of skin
components. The structure of cell type distribu-
tion is the relevant information for skin pathology,
similar to the state of the art hematoxylin and eosin
staining. The misclassification of specific cell lines
(e.g., A-375 cells classified as NIH-3T3) is critical
for a cell biological application where an identifi-
cation of cell lines would be desirable. From a di-
agnostic point of view, the detection of cell type
distribution and the much higher information con-
tent of tissue samples may be sufficient for the de-
velopment of a digital pathology system. Hence,
the current technologies and methodologies has the
potential for a transfer to the clinical practice but
needs more training and the reduction of prepara-
tion related informations.
5. Conclusions
The potential application of the current state-
of-the-art FTIR technology to cytopathological di-
agnosis has been assessed. A dataset of approxi-
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mately 22700 cultured cells, derived from two tu-
moral and two non-tumoral skin cell lines, has been
analysed to evaluate the discrimination capabili-
ties of current FTIR technology in cytopathologi-
cal problems. This number of analysed cells is rel-
atively high when compared with existing studies.
The analysed cells were distributed across three dif-
ferent batches, which were prepared and measured
at different time points by following similar proto-
cols to maximise uniformity between batches. How-
ever, these controlled protocols are limited by cur-
rent technological and procedural restrictions, e.g.,
the lack of an isolation chamber for the measured
samples. Therefore, external perturbations were in-
evitably introduced both during sample prepara-
tion and spectral acquisition.
Different methodologies and approaches have
been explored to process FTIR hyperspectral im-
ages and correctly analyse cell spectra through-
out the whole discrimination pipeline. Excellent
discrimination results are obtained when the algo-
rithms are trained and tested with cell spectra from
the same batch. However, those results for a spe-
cific cell line identification are not confirmed when
cells from different batches are mixed to construct
the algorithms and they are finally applied to a dif-
ferent batch. This fact questions the capabilities
of the discriminative properties of FTIR spectra of
low content cell biological samples, which seems to
be critically influenced by the differential factors
between batches, such as the sample preparation
protocol or the measurement conditions (e.g., dif-
ferent water vapour content).
Experimental design of future studies should as-
sess if the good results observed between cell lines of
the same batches are driven by genuine biochemical
differences rather than artificial perturbations in-
troduced by sample preparation and measurement
protocols. In any case, the high rates or misclassi-
fication for some cell lines in different batches warn
about the need of a better standardisation of the
aforementioned protocols, together with the specific
analysis methodologies. This is fundamental to de-
velop and establish a reliable technology for cell bi-
ological studies based on FTIR microspectroscopy
in the near future.
Further development of standardisation protocols
is needed, which will also have to incorporate and
adapt to the existing routine procedures of biomed-
ical laboratories. Additional improvements can be
introduced in the different steps of the proposed
discrimination pipeline apart from the experimen-
tal improvements. Regarding spectral analysis, it
is expected that the most relevant factors may be
the preprocessing and the supervised classification
framework. In the case of preprocessing, more com-
plex techniques for the removal of interferences such
as water vapour should be explored in case that
measurements could not be performed in isolated
environments. Authors would like to point out that
different trials were made to remove or at least
reduce the water vapour interferences by spectral
processing. However, unsuccessful results were ob-
tained due to the pixel variability in water vapour
signals introduced by FPA detectors as well as their
high sensitivity to the environmental conditions. In
addition, new advances in algorithms for the correc-
tion of RMieS, with higher computing speed, more
stability and robustness against perturbations (e.g.,
again water vapour), should be incorporated.
Finally, the biomedical relevance and the extrap-
olation of the results obtained with cultured cells
are limited because they are grown in artificial con-
ditions and have a rather low information content.
Therefore, the development of a reliable diagnostic
decision support system will necessarily have to use
FTIR spectra of patient cells and tissues with a ref-
erence ground truth provided by pathologists, such
as in histopathological studies. The here presented
data demonstrate the current capabilities, limita-
tions and future possibilities of FTIR spectroscopy
for cell biological and pathological applications. A
solution of the detected problems in sample prepa-
ration and data classification would open a wide
field of biomedical applications in the identification
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